Journals / European Journal of Therapeutics / 2021 / Cilt: 27 - Sayı: 1

Features of Childhood Colorectal Carcinomas and Frequency of K-ras Mutations

Pages
20–25
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overallsurvival rates at 3 and 5 years were 10%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Colorectal carcinoma (CRC) is extremely rare in childhood and has a poor prognosis in young patients.
📊
Key Findings & Data:This study aimed to investigate the features and outcomes of childhoodCRC as well as examine the frequency of K-ras mutations in CRC among children and adolescents.Methods: The clinical and pathologic features, prognostic factors, and outcomes of CRC in 28 children and adolescents (ages 10to 17 years) referred to the Pediatric Oncology Department of Hacettepe University Children’s Hospital between 1974 and 2010were reviewed for this study.
💡
Conclusion & Impact:Overallsurvival rates at 3 and 5 years were 10%.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Colorectal carcinoma (CRC) is extremely rare in childhood and has a poor prognosis in young patients. The tumorigenesis of CRC in children and adolescents is still unclear and probably evolves through different stages. There are not enough studiesabout the rarity of K-ras mutations with childhood CRC. This study aimed to investigate the features and outcomes of childhoodCRC as well as examine the frequency of K-ras mutations in CRC among children and adolescents.Methods: The clinical and pathologic features, prognostic factors, and outcomes of CRC in 28 children and adolescents (ages 10to 17 years) referred to the Pediatric Oncology Department of Hacettepe University Children’s Hospital between 1974 and 2010were reviewed for this study. Paraffin-embedded tissues of 18 patients were available and these tissues were analyzed by using the“pyrosequencing” method to detect K-ras mutations.Results: The median age of patients was 14 years and the male/female ratio was 2.5/1. At presentation, the most common symptoms were abdominal pain (57%) and weight loss (43%). The time between symptoms and diagnosis was 4 months. The mostcommon sites of involvement were the rectum (43%) and sigmoid colon (25%). Mucinous adenocarcinoma was the most common histiotype (71%). At presentation, 89% of patients had metastatic disease, especially to the peritoneal surface (39%). Overallsurvival rates at 3 and 5 years were 10%. Distant stage (p=0.045), incomplete resection, and macroscopic tumor (p=0.000) werepoor prognostic outcomes. A K-ras mutation was identified in three of the 18 patients (17%). The most common mutation of thepatients was GGT→GAT at codon 12.Conclusion: Childhood colorectal carcinomas occur in a shorter time than in adults, with different histiotypes and more likelydifferent steps. It seems that K-ras mutation plays a role in this different biology of pediatric CRC. However, further studies areessential to investigate and understand the biology of childhood CRC.

🔖

Cite This Article

Orhan, D., Varan, A., Akyüz, C., Büyükpamukçu, M., Kutluk, T., Yalçın, B., Büyükcam, A. (2022). Features of Childhood Colorectal Carcinomas and Frequency of K-ras Mutations. European Journal of Therapeutics, Cilt: 27 - Sayı: 1, 20–25. https://ajindex.com/articles/512164

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Pappo AS, Radriguez-Galindo C, Furman WL. Management of Infrequent cancers of childhood In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia: Lipincott Williams & Wilkins; 2010. p. 1109-12
  2. Ferrari A, Rognone A, Casanova M, Zaffignani E, Piva L, Collini P, et al. Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr Blood Cancer 2008; 50: 588-93. [Crossref] 3. Ferrari A, Brecht IB, Gatta G, Schneider DT, Orbach D, Cecchetto G, et al. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer 2019; 110: 120-6. [Crossref] 4. Kravarusic D, Feigin E, Dlugy E, Steinberg R, Baazov A, Erez I, et al. Colorectal carcinoma in childhood: a retrospective multicenter study. J Pediatr Gastroenterol Nutr 2007; 44: 209-11. [Crossref] 5. Hill DA, Furman WL, Billups CA, Riedley SE, Cain AM, Rao BN, et al. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 2007; 25: 5808-14. [Crossref] 6. Durno C, Aronson M, Bapat B, Cohen Z, Gallinger S. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 2005; 54: 1146-50. [Crossref] 7. Palmirotta R, Savonarola A, Ludovici G, Marchis MLD, Covello R, Ettorre GM, et al. Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer. Folia Histochem Cytobiol 2011; 49: 729-33. [Crossref] 8. Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, et al. Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev 2006; 15: 1443-50. [Crossref] 9. Kressner U, Bjorheim J, Westring S, Wahlberg SS, Påhlman L, Glimelius B, et al. Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer 1998; 34: 518-21. [Crossref] 10. Sherlock P, Lipkin M, Winawer SJ. Predisposing factors in carcinoma of the colon. Adv Intern Med 1975; 20: 121-50
  3. Poehlmann A, Kuester D, Meyer F, Lippert H, Roessner A, Schneider-Stock R. K-ras mutation detection in colorectal cancer using the Pyrosequencing technique. Pathol Res Pract 2007; 203: 489-97. [Crossref] 12. Gao J, Li YY, Sun PN, Shen L. Comparative analysis of dideoxy sequencing, the K